<p>CNS Pharmaceuticals Inc. has announced the appointment of Rami Levin as its new President and Chief Executive Officer, effective January 1, 2026. John Climaco has stepped down from his role as CEO. Rami Levin brings experience from previous leadership positions at Saniona, ImStem Biotechnology, Sobi, Merck Serono, and Schering AG. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CNS Pharmaceuticals Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1118481) on December 17, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

CNSP

<p>CNS Pharmaceuticals Inc. has appointed Rami Levin as its new President and CEO, effective January 1, 2026, succeeding John Climaco. Levin brings experience from leadership roles at Saniona, ImStem Biotechnology, Sobi, Merck Serono, and Schering AG.</p>

CNS Pharmaceuticals Appoints Rami Levin as CEO